Evidence map›Paper›PMID 30800188›Full record

ArticleDisease markers2019

Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal Cancer.

Milica Stojkovic Lalosevic, Aleksandra Pavlovic Markovic, Sanja Stankovic, Mirjana Stojkovic, Ivan Dimitrijevic, Irena Radoman Vujacic, Daria Lalic, Tamara Milovanovic, Igor Dumic, Zoran Krivokapic

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 4 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 4 syntheses or guidelines pooled it, 183 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Trial
  6. Article
  7. A drop of blood, a hint of risk: neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as early predictors and risk stratifiers in pyogenic spondylodiscitis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Expression of VISTA on T cells in patients with cancer colon.Journal of the Egyptian National Cancer Institute · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Milica Stojkovic LalosevicClinic of Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia.ORCID 0000-0003-4836-4439
Aleksandra Pavlovic MarkovicClinic of Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia.
Sanja StankovicCenter for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.
Mirjana StojkovicClinic of Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia.
Ivan DimitrijevicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Irena Radoman VujacicClinic of Gastroenterology, Clinical Center of Montenegro, Podgorica, Montenegro.
Daria LalicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
Tamara MilovanovicClinic of Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia.
Igor DumicMayo Clinic College of Medicine, Rochester, MN, USA.ORCID 0000-0002-5312-8812
Zoran KrivokapicFaculty of Medicine, University of Belgrade, Belgrade, Serbia.
University of Belgrade · RSCentar za Promociju Nauke · RSMayo Clinic · USUniversity of Montenegro · ME

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSystemic inflammation in colorectal cancer (CRC) may be reflected by neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV). This study was designed to investigate the efficiency of preoperative NLR, PLR, and MVP as a tool for the assessment of tumor characteristics in newly diagnosed patients with CRC. PATIENTS AND

methodsFor 300 patients and 300 healthy volunteers, complete blood counts with automated differential counts were performed. The NLR was calculated by dividing the absolute neutrophil count by the absolute lymphocyte count; PLR was calculated by dividing the absolute platelet count by the absolute lymphocyte count. The diagnostic performance of NLR, PLR, and MVP was estimated by ROC curve.

resultsROC curve analysis showed high diagnostic efficacy of NLR and PLR in CRC patients with cut-off values of 2.15 (AUC = 0.790, 95% CI 0.736-0.884, Se = 74.1%, and Sp = 73%) and 123 (AUC = 0.846, 95% CI 0.801-0.891, Se = 73.5%, and Sp = 80%) compared to healthy controls, respectively. The diagnostic efficacy of three combined markers was superior compared with individual markers (AUC = 0.904, 95% CI 0.812-0.989, Se = 96%, and Sp = 70%).

conclusionNRL, PLR, and MPV may be useful markers in diagnostic and early recognition of different stages of CRC; additionally combined all together have stronger diagnostic efficacy.

Indexed as

AgedBiomarkers, TumorColorectal NeoplasmsFemaleHumansLymphocyte CountMaleMean Platelet VolumeMiddle AgedPlatelet CountBiomarkers, Tumor

Identifiers

PMID30800188
PMCPMC6360046
OpenAlexW2909702642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.